These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 29414433)
1. IL-6 expression is correlated with increased T-cell proliferation and survival in the arterial wall in giant cell arteritis. Manku S; Wong W; Luo Z; Seidman MA; Alabdurubalnabi Z; Rey K; Enns W; Avina-Zubieta JA; Shojania K; Choy JC Cardiovasc Pathol; 2018; 33():55-61. PubMed ID: 29414433 [TBL] [Abstract][Full Text] [Related]
2. Temporal small arterial inflammation is common in patients with giant cell arteritis. Zhao CL; Hui Y; Amin A Hum Pathol; 2018 Nov; 81():65-70. PubMed ID: 29953896 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis. Coit P; De Lott LB; Nan B; Elner VM; Sawalha AH Ann Rheum Dis; 2016 Jun; 75(6):1196-202. PubMed ID: 26038090 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis. Bolha L; Hočevar A; Suljič A; Jurčić V Front Immunol; 2021; 12():791099. PubMed ID: 35003111 [TBL] [Abstract][Full Text] [Related]
6. Giant cell vasculitis is a T cell-dependent disease. Brack A; Geisler A; Martinez-Taboada VM; Younge BR; Goronzy JJ; Weyand CM Mol Med; 1997 Aug; 3(8):530-43. PubMed ID: 9307981 [TBL] [Abstract][Full Text] [Related]
7. An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis. Schaufelberger C; Andersson R; Nordborg E; Hansson GK; Nordborg C; Wahlström J Inflammation; 2008 Dec; 31(6):372-83. PubMed ID: 18975064 [TBL] [Abstract][Full Text] [Related]
8. MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis. Watanabe R; Maeda T; Zhang H; Berry GJ; Zeisbrich M; Brockett R; Greenstein AE; Tian L; Goronzy JJ; Weyand CM Circ Res; 2018 Aug; 123(6):700-715. PubMed ID: 29970365 [TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Wagner AD; Björnsson J; Bartley GB; Goronzy JJ; Weyand CM Am J Pathol; 1996 Jun; 148(6):1925-33. PubMed ID: 8669478 [TBL] [Abstract][Full Text] [Related]
10. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994 [TBL] [Abstract][Full Text] [Related]
11. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis. Espígol-Frigolé G; Corbera-Bellalta M; Planas-Rigol E; Lozano E; Segarra M; García-Martínez A; Prieto-González S; Hernández-Rodríguez J; Grau JM; Rahman MU; Cid MC Ann Rheum Dis; 2013 Sep; 72(9):1481-7. PubMed ID: 22993227 [TBL] [Abstract][Full Text] [Related]
12. The Immunopathology of Giant Cell Arteritis Across Disease Spectra. Robinette ML; Rao DA; Monach PA Front Immunol; 2021; 12():623716. PubMed ID: 33717128 [TBL] [Abstract][Full Text] [Related]
13. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. Ma-Krupa W; Jeon MS; Spoerl S; Tedder TF; Goronzy JJ; Weyand CM J Exp Med; 2004 Jan; 199(2):173-83. PubMed ID: 14734523 [TBL] [Abstract][Full Text] [Related]
14. T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis. Andersson R; Jonsson R; Tarkowski A; Bengtsson BA; Malmvall BE Ann Rheum Dis; 1987 Dec; 46(12):915-23. PubMed ID: 2962542 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis. Terrier B; Geri G; Chaara W; Allenbach Y; Rosenzwajg M; Costedoat-Chalumeau N; Fouret P; Musset L; Benveniste O; Six A; Klatzmann D; Saadoun D; Cacoub P Arthritis Rheum; 2012 Jun; 64(6):2001-11. PubMed ID: 22147555 [TBL] [Abstract][Full Text] [Related]
16. Mucosal-associated invariant T cells in Giant Cell Arteritis. Ghesquière T; Ciudad M; Ramon A; Greigert H; Gerard C; Cladière C; Thébault M; Genet C; Devilliers H; Maurier F; Ornetti P; Quipourt V; Gabrielle PH; Creuzot-Garcher C; Tarris G; Martin L; Soudry-Faure A; Saas P; Audia S; Bonnotte B; Samson M J Autoimmun; 2021 Jul; 121():102652. PubMed ID: 34000675 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of interleukin-22 in patients with giant cell arteritis. Zerbini A; Muratore F; Boiardi L; Ciccia F; Bonacini M; Belloni L; Cavazza A; Cimino L; Moramarco A; Alessandro R; Rizzo A; Parmeggiani M; Salvarani C; Croci S Rheumatology (Oxford); 2018 Jan; 57(1):64-72. PubMed ID: 28968695 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of giant cell arteritis: new insight into the implication of CD161+ T cells. Samson M; Audia S; Martin L; Janikashvili N; Bonnotte B Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S65-73. PubMed ID: 23663684 [TBL] [Abstract][Full Text] [Related]
19. Production of interleukin 6 by granulomas of giant cell arteritis. Emilie D; Liozon E; Crevon MC; Lavignac C; Portier A; Liozon F; Galanaud P Hum Immunol; 1994 Jan; 39(1):17-24. PubMed ID: 8181959 [TBL] [Abstract][Full Text] [Related]